文献速递肿瘤 PET/CT

18F-FAPI在小复发灶中浓聚而18F-FDG PET/CT阴性:一例混合型肝细胞-胆管癌

Intense 18 F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18 F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2024-03-07

一例70岁男性混合型肝细胞-胆管癌患者,约3个月前接受部分肝切除和放化疗,随访腹部超声发现肝I段新发小低回声病灶疑复发。患者入组比较18F-FDG与18F-FAPI PET/CT的临床试验,18F-FDG无摄取而18F-FAPI呈浓聚,切除后病理证实为复发性混合型肝细胞-胆管癌。

要点

  • 混合型肝细胞-胆管癌小复发灶可表现为18F-FDG PET/CT阴性而18F-FAPI浓聚。
  • 随访超声发现肝I段新发小低回声病灶,提示复发可能。
  • 病灶切除后病理分析证实为复发性混合型肝细胞-胆管癌。

核心结论

  • 18F-FAPI PET/CT在小复发灶中呈浓聚而18F-FDG PET/CT阴性,切除后病理证实为复发性混合型肝细胞-胆管癌。

研究设计与样本

  • 一例70岁男性混合型肝细胞-胆管癌患者,约3个月前接受部分肝切除和放化疗,因随访超声疑复发而入组比较18F-FDG与18F-FAPI PET/CT的临床试验。

主要发现

  • 随访腹部超声在肝I段检出新的小低回声病灶,可能提示复发。
  • 与18F-FDG无摄取相比,18F-FAPI PET/CT显示该肝病灶浓聚。
  • 病灶切除后病理分析证实为复发性混合型肝细胞-胆管癌。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 70-year-old man presented with combined hepatocellular-cholangiocarcinoma underwent partial hepatectomy and chemoradiotherapy approximately 3 months ago. Follow-up abdominal ultrasound detected a new small lesion with decreased echogenicity in the hepatic segment I, potentially indicating recurrence. The patient was enrolled in a clinical trial of comparison of 18 F-FDG and 18 F-FAPI PET/CT in hepatic lesions. Compared with non- 18 F-FDG avidity, 18 F-FAPI PET/CT showed intense tracer uptake of the hepatic lesion. Resection of the lesion was subsequently performed, and pathologic analysis confirmed the diagnosis of recurrent combined hepatocellular-cholangiocarcinoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Liang J, Zhang J, Song J, et al. Intense 18 F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18 F-FDG PET/CT. Clin Nucl Med. 2024. PMID: 38569540. doi:10.1097/RLU.0000000000005148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。